O
EGRX

OrbiMed’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

OrbiMed’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-671,000
Closed -$55.7M – 143
2017
Q1 		$55.7M Hold
671,000
– – 0.63% 47
2016
Q4 		$53.2M Sell
671,000
-365,100
-35% -$29M 0.68% 48
2016
Q3 		$72.5M Hold
1,036,100
– – 0.83% 47
2016
Q2 		$40.2M Buy
+1,036,100
New +$40.2M 0.42% 56